Abstracts tagged "biopsies and classification criteria"

Abstract Number: 1284 • 2019 ACR/ARP Annual Meeting
Idiopathic Inflammatory Myopathies: Are Muscle Biopsies Still Needed?
Belén Virasoro¹, Ramiro Gomez ², Andrea Braillard Poccard ³, Dafne Capelusnik ⁴, Emilce Schneeberger ⁵, Silvia Papasidero ⁶, Juan Bande ⁶, Malena Viola ⁷, Maria de la Vega ⁸, Carolina Costi ⁹, Mercedes Garcia ¹⁰, Cecilia Asnal ¹¹, Ana Cappuccio ¹², Demelza Yucra ¹³, Linda Vergel Orduz ¹⁴, Natalia Tamborenea ¹⁵, Mariano Rivero ¹⁶, Amelia Granel ¹⁷, Carolina Segura Escobar ¹⁶, Marina Dalpiaz ¹⁵ and Cecilia Pisoni ¹⁸, ¹CEMIC, buenos aires, Buenos Aires, Argentina, ²Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, ³Hospital de Clínicas José de San Martin, Buenos Aires, Buenos Aires, Argentina, ⁴Instituto de Rehabilitacion Psicofisica, CABA, Ciudad Autonoma de Buenos Aires, Argentina, ⁵Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁶Hospital General de Agudos Dr. E. Tornú, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, ⁷Hospital Argerich, Argentina, Buenos Aires, Argentina, ⁸CEIM Investigaciones Medicas, Buenos Aires, Argentina, ⁹Hospital General “San Martín” de la Plata, La Plata, Buenos Aires, Argentina, ¹⁰Hospital San Martín, La Plata, Argentina, ¹¹Instituto Centenario, Buenos Aires, Buenos Aires, Argentina, ¹²Hospital Francés, Buenos Aires, Buenos Aires, Argentina, ¹³Sanatorio Güemes, Buenos Aires, Buenos Aires, Argentina, ¹⁴Sanatorio Gúemes, Buenos Aires, Buenos Aires, Argentina, ¹⁵Hospital Rivadavia, Buenos Aires, Buenos Aires, Argentina, ¹⁶Hospital Británico, Buenos Aires, Buenos Aires, Argentina, ¹⁷Hospital San Roque,Gonnet,La Plata,Buenos Aires.Argentina, La Plata, Buenos Aires, Argentina, ¹⁸Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: Inflammatory myopathies (IM) are a heterogeneous group of diseases characterized by muscle inflammation. In Argentina, there are few pathologists specialized in muscle biopsies and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].